Archive 2012

Decisions Extraordinary General Meeting of Shareholders

At the Extraordinary General Meeting of Shareholders of Mediq on Thursday 20 December, the Supervisory Board and the Managing Board of Mediq, international supplier of medical devices and pharmaceuticals, elucidated on the bid of Advent International for all the outstanding shares of Mediq.

  1. Mediq finalises acquisition A-Med in US
  2. Offer update - All regulatory approvals obtained
  3. Recommended all-cash public offer by Advent for all issued and outstanding Mediq shares
  4. Marc van Gelder re-appointed Chief Executive Officer at Mediq
  5. Q3: Further growth in sales of medical devices; decrease in sales from pharmaceuticals  
  6. Mediq acquires leading position in Californian homecare market
  7. Advent intends to make recommended all-cash full public offer for Mediq 
  8. Mediq announces restructuring Pharmacies Netherlands
  9. ACP Pharma buys shares in Cefarm Rzeszów after public auction
  10. Mediq announces exchange ratio for interim dividend
  11. Q2: Pharmacies Netherlands result further decreases 12% sales growth at Direct & Institutional
  12. Biense Visser steps down from Supervisory Board
  13. Mediq announces exchange ratio 2011 final dividend
  14. Hans Janssen re-appointed Chief Financial Officer at Mediq
  15. Mediq transfers pension scheme to industry pension fund PMA 
  16. Q1: Lower result at Pharmacies Netherlands - Further growth of sales and result at Direct & Institutional
  17. Decisions annual General Meeting of Shareholders
  18. Q4 2011: International buy and build strategy leads to higher result - Outlook 2011 realised